U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257796) titled 'Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score' on Sept. 28.
Brief Summary: The endoscopic grading system (EGGIM) has been widely used to assess the extent of gastric intestinal metaplasia during endoscopy. Investigators developed an artificial intelligence (AI) system to automatically evaluate the extent of gastric intestinal metaplasia (GIM) and calculate the EGGIM scores in endoscopy examination. This study is a prospective, multi-center study aimed at exploring the performance and reliability of AI-EGGIM scoring.
This is a prospective study designed to validate the AI-EGGIM system in a lar...